FDA Warning Letter — Legacy/Gulf
The FDA took a Warning Letter action against Legacy/Gulf on Jun 1, 2017 (Dallas, TX). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- Legacy/Gulf
- Date
- Jun 1, 2017
- Fiscal Year
- 2017
- Product Type
- Tobacco
- Center
- CTP
- Location
- Dallas, TX (United States)